SMMT Summit Therapeutics Inc.

NEUTRAL Impact: 3/10 Institutional Cluster
Horizon weeks Processed 1d 23h ago
Institutional cluster: 3 buyers, 0 sellers (bullish)

Executive Summary

Three mega-passive institutional investors (Vanguard, State Street, Morgan Stanley) collectively added $122.6M to their SMMT positions in Q3 2025, with Morgan Stanley doubling its stake. The cluster is entirely passive/index-driven, not active manager conviction, and the 45-day reporting lag means positions may have been adjusted since quarter-end. Historical reports on SMMT have underperformed significantly (0% win rate at T+20, avg -19%), suggesting caution despite the buying.

Key Financial Metrics

Direction
accumulating
Buy Value
$406.4M
Sell Value
$0.00
Net Flow
$122.6M

Institutional Positions

Net institutional flow: $122.6M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Vanguard ADD +31.2% $235.1M $50.5M
State Street ADD +58.3% $131.4M $45.9M
Morgan Stanley DOUBLED +200.1% $39.8M $26.1M

Actionable Insight

The buying is entirely passive/index-driven, not active manager conviction — likely reflecting SMMT's inclusion in or rebalancing within major indices. With historical reports on SMMT showing 0% win rate at T+20 and avg -19% returns, treat this as a neutral data point. Monitor for any active manager 13F filings in the coming weeks that could signal genuine conviction.

Key Facts

  • 3 institutional buyers added $122.6M net in Q3 2025, with zero sellers
  • All three buyers are mega-passive/index funds (Vanguard, State Street, Morgan Stanley)
  • Morgan Stanley doubled its position (+200.1%, from $13.7M to $39.8M)
  • Vanguard added $50.5M (+31.2% shares) and State Street added $45.9M (+58.3% shares)
  • Total current holdings from these three funds: $406.4M
  • Historical SMMT reports show 0% win rate at T+20 with avg -19% return

Financial Impact

Three passive funds accumulated $122.6M in new SMMT positions during Q3 2025, bringing combined holdings to $406.4M

institutional ownershipfloat

Risk Factors

  • 45-day reporting lag means positions may have been unwound since quarter-end
  • All buyers are passive/index funds — no active manager conviction signal
  • Historical SMMT reports have significantly underperformed (0% win rate, avg -19% T+20)
  • 13F data does not capture short positions or derivatives

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (24 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-SMMT-2025-Q3
10 reports for SMMT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SMMT — sortable, filterable
Type Now
Jun 12, 2026
today
Insider Cluster
BULLISH ★ 6/10
$13.60 awaiting T+1awaiting T+1
Jun 12, 2026
today
Institutional Cluster
MIXED ★ 4/10
$13.08 awaiting T+1awaiting T+1
Jun 11, 2026
1d ago
Institutional Cluster
NEUTRAL ★ 3/10
$13.03 awaiting T+1awaiting T+1
Jun 9, 2026
3d ago
S-3ASR
BEARISH ★ 7/10
$14.29 awaiting T+1awaiting T+1
Jun 4, 2026
8d ago
Insider Cluster
BULLISH ★ 5/10
$15.01 awaiting T+1awaiting T+1
Jun 4, 2026
8d ago
Insider Cluster
BULLISH ★ 6/10
$15.30 awaiting T+1awaiting T+1
Jun 3, 2026
9d ago
8-K
NEUTRAL ★ 3/10
$15.07 $14.84▼ −1.53%▼ −1.93%
Jun 1, 2026
11d ago
8-K
BULLISH ★ 7/10
$15.71 $14.86▼ −5.41%▼ −5.56%
Apr 30, 2026
6w ago
8-K
NEUTRAL ★ 5/10
$16.12 $16.98▲ +5.37%▲ +5.71%
Apr 17, 2026
8w ago
DEFA14A
NEUTRAL ★ 2/10
$25.12 $26.38▲ +5.02%▲ +5.67%
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (50h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access